Market Tracker

04/29 3:46pm ET
2.28
BATS BZX Real-Time Price
As of 3:46pm ET
 -0.03 / -1.30%
Today’s Change
1.18
Today|||52-Week Range
4.34
-8.06%
Year-to-Date
No recent news for Solazyme Inc.

Today’s Trading

Previous close2.31
Today’s open2.35
Day’s range2.24 - 2.36
Volume9,425
Average volume (3 months)764,698
Market cap$192.9M
Dividend yield--
Data as of 3:46pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+17.76%
Earnings growth (this year)+20.17%
Earnings growth (next 5 years)+683.60%
Revenue growth (last year)-23.61%
P/E ratioNM
Price/Sales4.31
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AKTXAkari Therapeutics P...+0.10+0.59%
PFNXPfenex Inc-0.35-4.10%
ENZYEnzymotec Ltd+0.05+0.58%
OSIROsiris Therapeutics ...-0.24-4.09%
Data as of 3:45pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$46.1M
Annual profit (last year)-$141.4M
Net profit margin-306.62%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
Chairman &
Chief Executive Officer
Jonathan S. Wolfson
Chief Operating &
Financial Officer
Tyler W. Painter
Corporate headquarters
San Francisco, California

Forecasts